Rekvina Laboratories Ltd (NSE: VINRKLB), ISIN INE092O01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VINRKLB last traded at ₹25.32 (+0.08%), with a 52-week range of ₹6.75 to ₹46.65 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 41.30%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 59/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.